FDA gives the green light for human trials against a new coronavirus therapy

03-Apr-2020
KEY POINTS FROM ARTICLE:

Food and Drug administration approved a new treatment idea against coronavirus for human trials.
Treatment is derived from stem cells in human placentas.
Natural killer cells in the placenta protects a baby from viruses inside the mother while in her womb.
Plans to give infusions of this stem cell therapy to patients in order to get the same protection.
This early stage trial will include up to 86 coronavirus patients with symptoms.
This stem cell therapeutic approach was developed by New Jersey biotech company Celularity.

May cause serious adverse effects if stem cells over attack normal lung cells

Mentioned in this article:

Resource Celularity - Cell therapeutics company

Resource FDA - Ensuring safety of drugs, medical supplies and food which is used daily.

Resource New York Times

Resource Paul Knoepfler - Professor at Department of Cell Biology and Human Anatomy, School of Medicine Genome Center at University of California, Davis

Resource Robert J. Hariri - Surgeon, biomedical scientist and serial entrepreneur in biomedicine and aerospace

Read full article on WebMD website
More Stem Cells information, news and resources
More Coronavirus information, news and resources